Cargando…

Purported Mcl-1 inhibitor marinopyrrole A fails to show selective cytotoxicity for Mcl-1-dependent cell lines

Detalles Bibliográficos
Autores principales:	Eichhorn, J M, Alford, S E, Hughes, C C, Fenical, W, Chambers, T C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920948/ https://www.ncbi.nlm.nih.gov/pubmed/24157874 http://dx.doi.org/10.1038/cddis.2013.411

Ejemplares similares

Cyclic Marinopyrrole Derivatives as Disruptors of Mcl-1 and Bcl-x(L) Binding to Bim
por: Cheng, Chunwei, et al.
Publicado: (2014)

Marinopyrrole Derivatives with Sulfide Spacers as Selective Disruptors of Mcl-1 Binding to Pro-Apoptotic Protein Bim
por: Cheng, Chunwei, et al.
Publicado: (2014)

Male sterility in Mcl-1-flox mice is not due to enhanced Mcl1 protein stability
por: Ah-Cann, Casey, et al.
Publicado: (2016)

The MCL-1 BH3 Helix is an Exclusive MCL-1 inhibitor and Apoptosis Sensitizer
por: Stewart, Michelle L., et al.
Publicado: (2010)

The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines
por: Klenke, Stefanie, et al.
Publicado: (2019)

Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability
por: Tantawy, Shady I., et al.
Publicado: (2023)

MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas
por: Wang, Michelle Y., et al.
Publicado: (2021)

Mcl-1 levels need not be lowered for cells to be sensitized for ABT-263/737-induced apoptosis
por: Yamaguchi, R, et al.
Publicado: (2011)

Mcl-1 Ubiquitination and Destruction
por: Inuzuka, Hiroyuki, et al.
Publicado: (2011)

MCL-1ES Induces MCL-1L-Dependent BAX- and BAK-Independent Mitochondrial Apoptosis
por: Kim, Jae-Hong, et al.
Publicado: (2013)

Mcl-1 and tumor cell persistence
por: Pfannenstiel, Lukas W., et al.
Publicado: (2014)

MCL-1 inhibition in cancer treatment
por: Xiang, Weiguo, et al.
Publicado: (2018)

MCL1 as putative target in pancreatoblastoma
por: Reissig, Timm M., et al.
Publicado: (2022)

CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax
por: Kour, Smit, et al.
Publicado: (2019)

Co-inhibition of BCL-XL and MCL-1 with selective BCL-2 family inhibitors enhances cytotoxicity of cervical cancer cell lines
por: Abdul Rahman, Siti Fairus, et al.
Publicado: (2020)

Maritoclax and dinaciclib inhibit MCL-1 activity and induce apoptosis in both a MCL-1-dependent and -independent manner
por: Varadarajan, Shankar, et al.
Publicado: (2015)

A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation
por: Lee, Erinna F., et al.
Publicado: (2008)

A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
por: Zeidner, Joshua F., et al.
Publicado: (2021)

Mitotic arrest-induced phosphorylation of Mcl-1 revisited using two-dimensional gel electrophoresis and phosphoproteomics: nine phosphorylation sites identified
por: Chu, Rong, et al.
Publicado: (2016)

Small‐Molecule and Peptide Inhibitors of the Pro‐Survival Protein Mcl‐1
por: Beekman, Andrew M., et al.
Publicado: (2015)

A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine
por: Dart, Chiara R., et al.
Publicado: (2021)

Molecular docking analysis of MCL-1 inhibitors for breast cancer management
por: Abdulrahman, Alzahrani, et al.
Publicado: (2023)

MCL-1 Inhibitor S63845 Distinctively Affects Intramedullary and Extramedullary Hematopoiesis
por: Zhang, Hexiao, et al.
Publicado: (2023)

Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma
por: Zhang, Ao, et al.
Publicado: (2023)

Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing
por: Quentmeier, Hilmar, et al.
Publicado: (2016)

Regulation of Neutrophil Survival/Apoptosis by Mcl-1
por: Milot, Eric, et al.
Publicado: (2011)

Allosteric Inhibition of Anti-Apoptotic MCL-1
por: Lee, Susan, et al.
Publicado: (2016)

Targeting Mcl-1 for Radiosensitization of Pancreatic Cancers()()
por: Wei, Dongping, et al.
Publicado: (2015)

Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies
por: Kasper, S, et al.
Publicado: (2012)

Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
por: Al-Odat, Omar S., et al.
Publicado: (2021)

Overcoming MCL-1-driven adaptive resistance to targeted therapies
por: Wood, Kris C.
Publicado: (2020)

Outcomes Following ACL and Grade III MCL Injuries: Is there a Role for MCL Repair?
por: Westermann, Robert W., et al.
Publicado: (2017)

PorthoMCL: Parallel orthology prediction using MCL for the realm of massive genome availability
por: Tabari, Ehsan, et al.
Publicado: (2017)

Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes
por: Seiller, Carolane, et al.
Publicado: (2020)

Which Fibers of the Medial Collateral Ligament (MCL) Should Be Released in the Pie Crust Technique Applied During Knee Arthroscopy: Superficial MCL or Deep MCL?
por: Arıcan, Gökhun, et al.
Publicado: (2021)

DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complex
por: Nakajima, Wataru, et al.
Publicado: (2016)

Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening
por: Mady, Ahmed S. A., et al.
Publicado: (2018)

Multiple components of the spliceosome regulate Mcl1 activity in neuroblastoma
por: Laetsch, T W, et al.
Publicado: (2014)

Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
por: Murphy, Á. C., et al.
Publicado: (2013)

Mcl-1 is a key regulator of the ovarian reserve
por: Omari, S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_odbp25s1832dae7mfp92jk13gp